Literature DB >> 17068142

Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes.

Yanfang Liu1, M Dodson Michael, Shera Kash, William R Bensch, Brett P Monia, Susan F Murray, Keith A Otto, Samreen K Syed, Sanjay Bhanot, Kyle W Sloop, John M Sullivan, Anne Reifel-Miller.   

Abstract

Adiponectin/adiponectin receptors (AdipoR) are involved in energy homeostasis and inflammatory pathways. To investigate the role of AdipoR2 in metabolic control, we studied the lipid and glucose metabolic phenotypes in AdipoR2-deficient mice. AdipoR2 deletion diminished high-fat diet-induced dyslipidemia and insulin resistance yet deteriorated glucose homeostasis as high-fat feeding continued, which resulted from the failure of pancreatic beta-cells to adequately compensate for the moderate insulin resistance. A defect in the AdipoR2 gene may represent a mechanism underlying the etiology of certain subgroups of type 2 diabetic patients who eventually develop overt diabetes, whereas other obese patients do not.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068142     DOI: 10.1210/en.2006-0708

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  48 in total

1.  Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.

Authors:  Caroline M W van Stijn; Jason Kim; Aldons J Lusis; Grant D Barish; Rajendra K Tangirala
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

Review 2.  Adipokines and insulin resistance.

Authors:  Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Journal:  Mol Med       Date:  2008-09-17       Impact factor: 6.354

Review 3.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

4.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice.

Authors:  Martin S Denzel; Maria-Cecilia Scimia; Philine M Zumstein; Kenneth Walsh; Pilar Ruiz-Lozano; Barbara Ranscht
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

Review 5.  What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 6.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

Review 7.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 8.  Adipokines and the peripheral and neural control of energy balance.

Authors:  Rexford S Ahima; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2008-01-17

9.  Full-length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino Acid transport in human primary trophoblast cells.

Authors:  Helen N Jones; Thomas Jansson; Theresa L Powell
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

10.  Systemic fate of the adipocyte-derived factor adiponectin.

Authors:  Nils Halberg; Todd D Schraw; Zhao V Wang; Ja-Young Kim; James Yi; Mark P Hamilton; Kate Luby-Phelps; Philipp E Scherer
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.